BioCentury
ARTICLE | Editor's Commentary

Finding opportunity in chaos: Editor’s Commentary

How biopharma can navigate Trump 2.0

December 13, 2024 10:49 PM UTC

Washington is preparing for Trump 2.0. Businesses are hiring lobbyists who claim to have the ear of incoming officials, interest groups are putting the finishing touches on legislation that could appeal to the DOGE brothers, and civil servants are rewriting proposals to align them with the incoming administration’s populist predilections.

The overarching idea is to find opportunity in chaos. ...